HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gipson, T. G. Articles by Notkins, A. L. Search for Related Content PubMed Articles by Gipson, T. G. Articles by Notkins, A. L.

Interaction of Rheumatoid Factor with Infectious Vaccinia Virus-Antibody Complexes^1,2,

Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, and the Laboratory of Oral Medicine, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20014

Abstract

Rheumatoid factor (RF), isolated from sera of patients with rheumatoid arthritis, attached to infectious vaccinia virus-IgG (Vac-IgG) complexes. Neutralization did not occur until the Vac-IgG-RF complexes were incubated with either goat antihuman IgM or complement. The amount of RF that attached was proportional to the concentration of IgG incubated with the virus. The enhancement by RF of complement-mediated neutralization of Vac-IgG was not dependent upon the order of addition of the immunoreactants. Complement addition before, with, or after RF resulted in the same amount of neutralization. These observations suggest that under certain conditions RF may play a role in the defense against viral infections.

Footnotes

¹ This work was supported by United States Public Health Service Contract NIH-NIDR-72-2402.

² Preliminary results of this work were presented in part at the May 1973 meeting of the American Society for Microbiology.